Gernot Rohde1, Eberhard Straube, Andreas Essig, Petra Reinhold, Konrad Sachse. 1. Medizinische Klinik III, Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bürkle-de-la-Camp-Platz 1, Bochum, Germany. gernot.rohde@rub.de
Abstract
BACKGROUND: Zoonoses were already a subject of intense interest even before the SARS and avian influenza epidemics arose. For many years, chlamydiae have been hypothesized to be important zoonotic pathogens, because of their wide distribution and their infectious cycle. This article provides an overview of the current state of knowledge on this subject. METHODS: The authors present a selective review of the literature as well as their own findings. RESULTS: The scientific knowledge of the distribution and infectious cycle of chlamydiae is still inadequate. The laboratory diagnosis of chlamydial zoonoses remains unsatisfactory in both human and veterinary medicine, as there are no commercially available sensitive and species-specific tests. Acute chlamydial infections are usually treated with macrolides, tetracyclines, or quinolones. Persistent varieties are not covered by standard therapy. CONCLUSIONS: There is a considerable need for research on chlamydial infections, especially with regard to the diagnosis and treatment of persistent varieties.
BACKGROUND: Zoonoses were already a subject of intense interest even before the SARS and avian influenza epidemics arose. For many years, chlamydiae have been hypothesized to be important zoonotic pathogens, because of their wide distribution and their infectious cycle. This article provides an overview of the current state of knowledge on this subject. METHODS: The authors present a selective review of the literature as well as their own findings. RESULTS: The scientific knowledge of the distribution and infectious cycle of chlamydiae is still inadequate. The laboratory diagnosis of chlamydial zoonoses remains unsatisfactory in both human and veterinary medicine, as there are no commercially available sensitive and species-specific tests. Acute chlamydial infections are usually treated with macrolides, tetracyclines, or quinolones. Persistent varieties are not covered by standard therapy. CONCLUSIONS: There is a considerable need for research on chlamydial infections, especially with regard to the diagnosis and treatment of persistent varieties.
Authors: Maria Braukmann; Konrad Sachse; Ilse D Jacobsen; Martin Westermann; Christian Menge; Hans-Peter Saluz; Angela Berndt Journal: Infect Immun Date: 2012-06-11 Impact factor: 3.441
Authors: Pavel Dutow; Beate Fehlhaber; Jenny Bode; Robert Laudeley; Claudia Rheinheimer; Silke Glage; Rick A Wetsel; Oliver Pabst; Andreas Klos Journal: J Infect Dis Date: 2013-11-23 Impact factor: 5.226
Authors: Stina Englund; Carl Hård af Segerstad; Frida Arnlund; Eva Westergren; Magdalena Jacobson Journal: BMC Vet Res Date: 2012-01-26 Impact factor: 2.741
Authors: C DE Boeck; C Dehollogne; A Dumont; M Spierenburg; M Heijne; I Gyssens; J VAN DER Hilst; D Vanrompay Journal: Epidemiol Infect Date: 2015-12-16 Impact factor: 4.434
Authors: Petra Reinhold; Carola Ostermann; Elisabeth Liebler-Tenorio; Angela Berndt; Anette Vogel; Jacqueline Lambertz; Michael Rothe; Anke Rüttger; Evelyn Schubert; Konrad Sachse Journal: PLoS One Date: 2012-01-27 Impact factor: 3.240